|
⚲
|
| Keyboard |
| Gowen Maxine
✚
|
|
|---|---|
| CIK # | 0001280044 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001280044] | |
| 4 | [0001280044] | |
| 5 | [0001280044] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Aclaris Therapeutics Inc | |
| Gowen Maxine | |
| Passage Bio Inc | |
| Merus NV | |
| Idera Pharmaceuticals Inc | |
| Akebia Therapeutics Inc | |
| Trevena Inc | |
| Human Genome Sciences Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Merus NV MRUS
Share Option (right to buy) · derivative
|
2025-12-12 | Disposed to issuer | 8,844 | $0.00 | |
|
Merus NV MRUS
Share Option (right to buy) · derivative
|
2025-12-12 | Disposed to issuer | 13,193 | $0.00 | |
|
Merus NV MRUS
Share Option (right to buy) · derivative
|
2025-12-12 | Disposed to issuer | 7,957 | $0.00 | |
|
Merus NV MRUS
Share Option (right to buy) · derivative
|
2025-12-12 | Disposed to issuer | 16,604 | $0.00 | |
|
Merus NV MRUS
Share Option (right to buy) · derivative
|
2025-12-12 | Disposed to issuer | 12,240 | $0.00 | |
|
Merus NV MRUS
Share Option (right to buy) · derivative
|
2025-12-12 | Disposed to issuer | 14,414 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Common Stock
|
2025-06-06 | Option exercise | 4,793 | ||
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2025-06-06 | Option exercise | 4,793 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2025-06-05 | Grant | 11,580 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Stock Option (Right to Buy) · derivative
|
2025-06-05 | Grant | 42,350 | $0.00 | |
|
Passage Bio Inc PASG
Director Stock Option (right to buy) · derivative
|
2025-05-28 | Grant | 201,857 | $0.00 | |
|
Merus NV MRUS
Share Option (right to buy) · derivative
|
2025-05-22 | Grant | 13,193 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2024-06-06 | Grant | 4,793 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Stock Option (Right to Buy) · derivative
|
2024-06-06 | Grant | 15,750 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2024-06-01 | Option exercise | 4,660 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Common Stock
|
2024-06-01 | Option exercise | 4,660 | ||
|
Passage Bio Inc PASG
Director Stock Option (right to buy) · derivative
|
2024-05-21 | Grant | 47,693 | $0.00 | |
|
Merus NV MRUS
Share Option (right to buy) · derivative
|
2024-05-07 | Grant | 8,844 | $0.00 | |
|
Idera Pharmaceuticals Inc ACGN
Common Stock
|
2023-08-10 | Sell | 51 | $0.51 | 26 |
|
Merus NV MRUS
Share option (right to buy) · derivative
|
2023-06-08 | Grant | 14,414 | $0.00 | |
| showing 20 of 118 most recent transactions | |||||